Over 30 years in cross-border pharma between the US, EU, and Asia. Tony has led technology transfer, licensing, M&A, and manufacturing strategy on both sides of the Pacific, and directs TPP's re-shoring mandate at Nancy Ridge Drive.
25 years in biopharma finance and business development, including licensing and BD leadership at Merck. Michael was CEO of Castle Creek Pharma and is a Managing Partner at TardiMed Sciences.
US-based pharmaceutical development and manufacturing in San Diego, California.